A randomized, double-blind study to evaluate the safety and efficacy of etoricoxib 60 mg and diclofenac sodium [diclofenac] 150 mg in patient with osteoarthritis of the knee or hip

Trial Profile

A randomized, double-blind study to evaluate the safety and efficacy of etoricoxib 60 mg and diclofenac sodium [diclofenac] 150 mg in patient with osteoarthritis of the knee or hip

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs Diclofenac; Etoricoxib
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 12 Apr 2017 Last checked against ClinicalTrials.gov record.
    • 24 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top